- Home
- COR
COR
Cencora Inc.
as 12-20-2024 4:00pm EST
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | CONSHOHOCKEN |
| Market Cap: | 44.4B | IPO Year: | N/A |
| Target Price: | $268.09 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.53 | EPS Growth: | -11.72 |
| 52 Week Low/High: | $202.26 - $253.27 | Next Earning Date: | 01-29-2025 |
| Revenue: | $293,958,599,000 | Revenue Growth: | 12.12% |
| Revenue Growth (this year): | 9.1% | Revenue Growth (next year): | 6.60% |
Stock Insider Trading Activity of Cencora Inc. (COR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Krikorian Lazarus | COR | SVP & Chief Accounting Officer | Dec 3 '24 | Sell | $250.42 | 1,816 | $454,753.64 | 21,988 | |
| COLLIS STEVEN H | COR | Executive Chairman | Oct 22 '24 | Sell | $235.80 | 21,509 | $5,071,822.20 | 285,088 |
Latest Cencora Inc. News
COR Breaking Stock News: Dive into COR Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Cencora's (NYSE:COR) earnings growth rate lags the 23% CAGR delivered to shareholders
Zacks
6 days ago
Why Cencora (COR) is a Top Growth Stock for the Long-Term
TipRanks
8 days ago
Cencora price target lowered to $237 from $249 at Wells Fargo
Business Wire
12 days ago
Cencora Closes $1.8 Billion Senior Notes Offering
Simply Wall St.
15 days ago
We Think You Can Look Beyond Cencora's (NYSE:COR) Lackluster Earnings
Simply Wall St.
18 days ago
Possible Bearish Signals With Cencora Insiders Disposing Stock
Business Wire
19 days ago
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
Zacks
19 days ago
Here's Why Cencora (COR) is a Strong Momentum Stock
Compare COR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COR Cencora Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.